Vimarsana
Biggest News Aggregation in the World

Page 2 - Life Edit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Edit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Edit Today - Breaking & Trending Today

Top 11 CRISPR Stocks To Invest In - Vimarsana News

Top 11 CRISPR Stocks To Invest In

In this article, we discuss the top 11 CRISPR stocks to invest in. If you want to skip our discussion of the gene editing industry, head directly to Top 5 CRISPR Stocks To Invest In. Genome editing refers to a set of technologies enabling scientists to modify an organism’s DNA by adding, removing, or altering […]

Source: yahoo.com
ElevateBio to Highlight Growth of its Genetic Medicine Business Driven By Gene Editing and Manufacturing Partnerships at the 42nd Annual J.P. Morgan Healthcare Conference - Vimarsana News

ElevateBio to Highlight Growth of its Genetic Medicine Business Driven By Gene Editing and Manufacturing Partnerships at the 42nd Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass.--(BUSINESS WIRE)--Jan 8, 2024--

Obesity fighting success encourage Novo to try gene-editing tech - Vimarsana News

Obesity fighting success encourage Novo to try gene-editing tech

The plan focuses on seven programmes for rare genetic disorders, cardiometabolic diseases

Novo Nordisk strikes potential $2B-plus gene editing deal with Durham's Life Edit - Vimarsana News

Novo Nordisk strikes potential $2B-plus gene editing deal with Durham's Life Edit

Gene editing from a Durham-based firm that will target possible new therapeutics has led to a deal with international drug firm Novo Nordisk worth a potential $2 billion if not more. Here are the details.

Novo Nordisk and Life Edit Therapeutics establish multi-target collaboration to discover and develop gene editing therapies for rare and cardiometabolic diseases - Vimarsana News

Novo Nordisk and Life Edit Therapeutics establish multi-target collaboration to discover and develop gene editing therapies for rare and cardiometabolic diseases

Novo Nordisk and Life Edit Therapeutics, Inc., an ElevateBio company focused on next-generation gene editing technologies and therapeutics, today announced a research and development collaboration to discover and develop gene editing therapies against a select set of therapeutic targets. With a focus on advancing ...